$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

$sfes Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000008611517000131 Filed on October 26, 2017

Income Statement

Concept	2017 Q4	2017 Q3	2016 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.900M	$3.800M	$4.700M
YoY Change	0.0%	-19.15%	17.5%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$4.000M	$3.800M	$4.700M
YoY Change	2.56%	-19.15%	17.5%
Operating Profit	-$3.940M	-$3.758M	-$4.687M
YoY Change	0.31%	-19.82%	18.3%
Interest Expense	-$14.80M	-$14.90M	-$17.00M
YoY Change	-16.85%	-12.35%	102.38%
% of Operating Profit
Other Income/Expense, Net	-$120.0K	-$379.0K	-$2.405M
YoY Change	-287.5%	-84.24%	-441.62%
Pretax Income	-$18.73M	-$18.65M	-$24.09M
YoY Change	-13.7%	-22.57%	107.13%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$18.73M	-$18.65M	-$24.09M
YoY Change	-13.7%	-22.57%	107.13%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.91	-$0.91	-$1.18
Diluted Earnings Per Share	-$0.91	-$0.91	-$1.18
COMMON SHARES
Basic Shares Outstanding	20.41M shares	20.46M shares	20.39M shares
Diluted Shares Outstanding		20.46M shares	20.39M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$25.25M	$39.72M	$66.30M
YoY Change	-16.94%	-40.1%	-29.09%
Cash & Equivalents	$20.75M	$34.32M	$52.50M
Short-Term Investments	$4.500M	$5.400M	$13.80M
Other Short-Term Assets	$4.600M	$3.700M	$1.900M
YoY Change	119.05%	94.74%	-5.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$33.61M	$47.06M	$68.22M
YoY Change	3.25%	-31.02%	-28.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.513M	$1.626M	$1.955M
YoY Change	-19.22%	-16.83%	35.95%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$108.1M	$114.3M	$151.9M
YoY Change	-30.11%	-24.74%	4.79%
Other Assets	$316.0K	$316.0K	$296.0K
YoY Change	6.76%	6.76%	-84.45%
Total Long-Term Assets	$142.9M	$147.2M	$185.5M
YoY Change	-28.31%	-20.64%	3.25%
TOTAL ASSETS
Total Short-Term Assets	$33.61M	$47.06M	$68.22M
Total Long-Term Assets	$142.9M	$147.2M	$185.5M
Total Assets	$176.5M	$194.3M	$253.7M
YoY Change	-23.88%	-23.43%	-7.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$155.0K	$171.0K	$110.0K
YoY Change	10.71%	55.45%	-56.52%
Accrued Expenses	$1.851M	$2.495M	$3.136M
YoY Change	-16.73%	-20.44%	-13.94%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$40.49M	$40.10M
YoY Change
Total Short-Term Liabilities	$45.81M	$45.66M	$6.505M
YoY Change	681.64%	601.89%	-7.52%
LONG-TERM LIABILITIES
Long-Term Debt	$45.30M	$44.90M	$52.10M
YoY Change	-13.88%	-13.82%	1.36%
Other Long-Term Liabilities	$3.535M	$3.504M	$3.947M
YoY Change	-2.62%	-11.22%	0.48%
Total Long-Term Liabilities	$3.535M	$3.504M	$3.947M
YoY Change	-2.62%	-11.22%	0.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$45.81M	$45.66M	$6.505M
Total Long-Term Liabilities	$3.535M	$3.504M	$3.947M
Total Liabilities	$94.67M	$94.07M	$62.60M
YoY Change	52.56%	50.28%	0.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$715.5M	-$696.7M	-$605.2M
YoY Change	14.13%	15.13%	2.58%
Common Stock	$814.7M	$817.2M	$820.0M
YoY Change	-0.43%	-0.35%	-0.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$17.31M	$20.12M	$23.47M
YoY Change	-17.82%	-14.25%	29.8%
Treasury Stock Shares	999.0K shares	1.169M shares	1.335M shares
Shareholders Equity	$81.80M	$100.2M	$191.1M
YoY Change
Total Liabilities & Shareholders Equity	$176.5M	$194.3M	$253.7M
YoY Change	-23.88%	-23.43%	-7.78%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2016 Q3
OPERATING ACTIVITIES
Net Income	-$18.73M	-$18.65M	-$24.09M
YoY Change	-13.7%	-22.57%	107.13%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$5.300M	-$4.100M	-$3.300M
YoY Change	15.22%	24.24%	13.79%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$0.00
YoY Change	-100.0%		-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$8.200M	-$7.000M	-$10.40M
YoY Change	-57.29%	-32.69%	-238.67%
Cash From Investing Activities	-$8.200M	-$7.000M	-$10.40M
YoY Change	-57.95%	-32.69%	-240.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-100.0K	-2.700M	-100.0K
YoY Change		2600.0%	-93.75%
NET CHANGE
Cash From Operating Activities	-5.300M	-4.100M	-3.300M
Cash From Investing Activities	-8.200M	-7.000M	-10.40M
Cash From Financing Activities	-100.0K	-2.700M	-100.0K
Net Change In Cash	-13.60M	-13.80M	-13.80M
YoY Change	-43.57%	0.0%	-575.86%
FREE CASH FLOW
Cash From Operating Activities	-$5.300M	-$4.100M	-$3.300M
Capital Expenditures	$0.00	$0.00	$0.00
Free Cash Flow	-$5.300M	-$4.100M	-$3.300M
YoY Change	23.26%	24.24%	22.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000086115
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20412398	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	SAFEGUARD SCIENTIFICS INC
	dei	Trading Symbol TradingSymbol	SFE
CY2017Q3	sfe	Cash Cash Equivalents And Marketable Securities CashCashEquivalentsAndMarketableSecurities	39700000	USD
CY2015Q4	sfe	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents CashCashEquivalentsRestrictedCashandRestrictedCashEquivalents	32838000	USD
CY2016Q3	sfe	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents CashCashEquivalentsRestrictedCashandRestrictedCashEquivalents	52496000	USD
CY2016Q4	sfe	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents CashCashEquivalentsRestrictedCashandRestrictedCashEquivalents	28394000	USD
CY2017Q3	sfe	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents CashCashEquivalentsRestrictedCashandRestrictedCashEquivalents	40653000	USD
	sfe	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	19658000	USD
	sfe	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	12259000	USD
CY2017Q3	sfe	Cash Liabilityfor Performance Based Units CashLiabilityforPerformanceBasedUnits	0	USD
CY2001Q4	sfe	Future Annual Payment To Chairman And Chief Executive Officer FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer	650000	USD
CY2016Q3	sfe	Other Comprehensive Income Loss Reclassification Adjustmenton Saleof Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentonSaleofEquityMethodInvestments	0	USD
	sfe	Other Comprehensive Income Loss Reclassification Adjustmenton Saleof Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentonSaleofEquityMethodInvestments	0	USD
CY2017Q3	sfe	Other Comprehensive Income Loss Reclassification Adjustmenton Saleof Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentonSaleofEquityMethodInvestments	0	USD
	sfe	Other Comprehensive Income Loss Reclassification Adjustmenton Saleof Equity Method Investments OtherComprehensiveIncomeLossReclassificationAdjustmentonSaleofEquityMethodInvestments	50000	USD
CY2016Q3	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	3000	USD
	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	13000	USD
CY2017Q3	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	274000	USD
	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	277000	USD
CY2017Q3	sfe	Partner Companies Not Consolidated In Financial Statements PartnerCompaniesNotConsolidatedInFinancialStatements	26	nonconsolidated_partner_company
CY2017Q3	sfe	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Award Vesting Types SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofAwardVestingTypes	2	vesting_type
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	140000	USD
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	171000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2223000	USD
CY2017Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2495000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-431000	USD
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-104000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	816016000	USD
CY2017Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	815031000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	806000	USD
CY2016Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	25142000	USD
CY2017Q3	us-gaap	Advances To Affiliate AdvancesToAffiliate	20289000	USD
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	604000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1879000	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	560000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	806000	USD
CY2016Q4	us-gaap	Assets Assets	231828000	USD
CY2017Q3	us-gaap	Assets Assets	194285000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	32551000	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	47060000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22058000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34300000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34317000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	2157000	USD
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	2157000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-24082000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-548000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-18376000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-69517000	USD
CY2016Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	USD
CY2017Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	40148000	USD
CY2016Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	52560000	USD
CY2017Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	USD
CY2016Q4	us-gaap	Cost Method Investments CostMethodInvestments	3662000	USD
CY2017Q3	us-gaap	Cost Method Investments CostMethodInvestments	4096000	USD
CY2016Q3	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	20387000	USD
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	20390000	USD
CY2017Q3	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	20455000	USD
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	20416000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.42
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.42
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3498000	USD
CY2017Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2844000	USD
CY2016Q4	us-gaap	Equity Method Investments EquityMethodInvestments	154666000	USD
CY2017Q3	us-gaap	Equity Method Investments EquityMethodInvestments	114313000	USD
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4687000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14764000	USD
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3758000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13191000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	8384000	USD
CY2017Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	5171000	USD
CY2016Q4	us-gaap	Held To Maturity Securities Noncurrent HeldToMaturitySecuritiesNoncurrent	7302000	USD
CY2017Q3	us-gaap	Held To Maturity Securities Noncurrent HeldToMaturitySecuritiesNoncurrent	249000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24085000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-561000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18650000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-69844000	USD
CY2016Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-16345000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	17954000	USD
CY2017Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-12874000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-53373000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1161000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	3465000	USD
CY2017Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	2643000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	5953000	USD
CY2016Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	513000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1460000	USD
CY2017Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1004000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2892000	USD
CY2016Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	183470000	USD
CY2017Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	138698000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	62051000	USD
CY2017Q3	us-gaap	Liabilities Liabilities	94073000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	231828000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	194285000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5861000	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	45658000	USD
CY2016Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	USD
CY2017Q3	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	44911000	USD
CY2017Q3	us-gaap	Marketable Securities MarketableSecurities	5400000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5821000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	29686000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	39593000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1912000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14114000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15515000	USD
CY2016Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	0	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	0	USD
CY2017Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	0	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	0	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4687000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14764000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3758000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13191000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	296000	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	316000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	327000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3630000	USD
CY2017Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3504000	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2405000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1746000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-379000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-219000	USD
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	17741000	USD
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	16933000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5389000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5696000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	437000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	175000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	34841000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	11851000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	18733000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	73000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	0	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2017Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2017Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2109000	USD
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3691000	USD
	us-gaap	Proceeds From Collection Of Advance To Affiliate ProceedsFromCollectionOfAdvanceToAffiliate	1741000	USD
	us-gaap	Proceeds From Collection Of Advance To Affiliate ProceedsFromCollectionOfAdvanceToAffiliate	0	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	73854000	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	16604000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	50000000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	35386000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	10268000	USD
CY2016Q3	us-gaap	Profit Loss ProfitLoss	-24085000	USD
	us-gaap	Profit Loss ProfitLoss	-561000	USD
CY2017Q3	us-gaap	Profit Loss ProfitLoss	-18650000	USD
	us-gaap	Profit Loss ProfitLoss	-69844000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1873000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1626000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	14455000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	6336000	USD
CY2017Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	6336000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-626904000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-696748000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	-826000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-40000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	169777000	USD
CY2017Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	100212000	USD
CY2016Q4	us-gaap	Trading Securities TradingSecurities	0	USD
CY2017Q3	us-gaap	Trading Securities TradingSecurities	3881000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1209000	shares
CY2017Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	1169000	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	21061000	USD
CY2017Q3	us-gaap	Treasury Stock Value TreasuryStockValue	20124000	USD
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20387000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20390000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20455000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20416000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20387000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20390000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20455000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20416000	shares

Files In Submission

Name	View Source	Status
0000086115-17-000131-index-headers.html	Edgar Link	pending
0000086115-17-000131-index.html	Edgar Link	pending
0000086115-17-000131.txt	Edgar Link	pending
0000086115-17-000131-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sfe-20170930.xml	Edgar Link	completed
sfe-20170930.xsd	Edgar Link	pending
sfe-20170930_cal.xml	Edgar Link	unprocessable
sfe-20170930_def.xml	Edgar Link	unprocessable
sfe-20170930_lab.xml	Edgar Link	unprocessable
sfe-20170930_pre.xml	Edgar Link	unprocessable
sfe-2017xq3.htm	Edgar Link	pending
sfe-2017xq3xex311.htm	Edgar Link	pending
sfe-2017xq3xex312.htm	Edgar Link	pending
sfe-2017xq3xex321.htm	Edgar Link	pending
sfe-2017xq3xex322.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

2017 Q4 Form 10-Q Financial Statement

#000008611517000131 Filed on October 26, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES SAFEGUARD SCIENTIFICS INC Stock $sfes

2017 Q4 Form 10-Q Financial Statement

#000008611517000131 Filed on October 26, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes